The Insight Partners published latest research report on “Blood Plasma Derivatives Market Size Report, Growth, Trends and Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Application, and End User,” the global market size is expected to reach USD 51,119.24 million by 2028 from USD 29.886.12 million in 2022; it is estimated to record a CAGR of 9.4% from 2022 to 2028.
The Insight Partners published latest research report on “Blood Plasma Derivatives Market Size Report, Growth, Trends and Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Application, and End User,” the global market size is expected to reach USD 51,119.24 million by 2028 from USD 29.886.12 million in 2022; it is estimated to record a CAGR of 9.4% from 2022 to 2028.
Download PDF Brochure: https://www.theinsightpartners.com/sample/TIPRE00007250
Global Blood Plasma Derivatives Market Growth Drivers:
- Increasing prevalence of blood disorders: The rise in blood disorders such as hemophilia, thrombocytopenia, and von Willebrand disease has led to a greater demand for blood plasma derivatives as they offer effective treatment options.
- Technological advancements: The development of innovative technologies such as chromatography, ultrafiltration, and virus inactivation has increased the efficiency of blood plasma fractionation and purification, leading to higher yields of plasma derivatives.
- Growing demand for immunoglobulins: The increasing use of immunoglobulins in the treatment of autoimmune and infectious diseases has fueled the growth of the blood plasma derivatives market.
- Favorable regulatory environment: The regulatory environment has become more supportive of blood plasma derivative development, with streamlined approval processes and increased funding for research and development.
- Increasing investment in research and development: Blood plasma derivative companies are investing heavily in research and development, leading to the discovery of new plasma derivatives and treatments that are driving market growth.
Global Blood Plasma Derivatives Market Analysis - Recent Developments:
• The blood plasma derivatives market has seen significant developments in recent years. Plasma is the liquid component of blood that remains after the red and white blood cells, platelets, and other cellular components are removed. Plasma-derived products are used to treat a variety of conditions, including hemophilia, immune deficiencies, and other rare diseases.
• One significant development in the market has been the increased use of recombinant factor products for hemophilia treatment. These products are made using genetically engineered cells and can be more cost-effective and reliable than plasma-derived products.
• Another important development has been the increased focus on safety and quality in the manufacturing of plasma-derived products. This includes the implementation of rigorous testing and screening processes to ensure that products are free from infectious agents and meet high quality standards.
• The COVID-19 pandemic has also had an impact on the plasma derivatives market. The demand for plasma-derived therapies increased as these products were used to treat critically ill COVID-19 patients. However, the pandemic also disrupted the supply chain for plasma-derived products, leading to shortages in some areas.
Quickly Purchase Premium Copy of Blood Plasma Derivatives Market Size Report (2022-2028) at: https://www.theinsightpartners.com/buy/TIPRE00007250
Global Blood Plasma Derivatives Market Share Report, Segmentations, Regional & Country Scope:
| Report Coverage | Details |
| Market Size Value in | USD 29.886.12 million in 2022 |
| Market Size Value by | USD 51,119.24 million by 2028 |
| Growth rate | CAGR of 9.4% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2022 |
| No. of Pages | 209 |
| No. of Tables | 111 |
| No. of Charts & Figures | 80 |
| Historical data available | Yes |
| Segments covered | Type, Application, and End User |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Companies Covered | Grifols, S.A., SK Plasma Co., Ltd., Fusion Healthcare, Biotest AG, Green Cross Corp, Kedrion, LFB S.A., Octapharma AG, CSL Limited, Takeda Pharmaceutical Company Limited |
| Key Research Capabilities | Global Market Assessment, Business Development Strategies, Competitive Landscape, Opportunity Analysis, Regional and Country Level Market Analysis, Market Entry Strategies, Market Dynamics, Risk and Return Assessments, Pricing Analysis, Market Size and Forecasting, Company Profiling, Value Chain Analysis, Expansion Strategies, SWOT Analysis, New Product Development |
Browse key market insights spread across 209 pages with 111 list of tables & 80 list of figures from the report, “Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)” in detail along with the table of contents: https://www.theinsightpartners.com/reports/blood-plasma-derivatives-market
Plasma derivatives are obtained from explicit plasma proteins by the cycle of fractionation. Blood plasma derivatives contain a high amount of proteins, salts, minerals, hormones, vitamins, and protease inhibitors. Thus, they are commonly used to destroy viruses that trigger bleeding disorders, hepatitis B, hepatitis C, hemophilia A, immunodeficiency, hypogammaglobulinemia, hemophilia B, and human immunodeficiency virus.
The rising prevalence of antibodies deficiencies is driving the blood plasma derivatives market growth. Antibodies deficiency represents the most type of deficiencies in human. Furthermore, increasing geriatric population and rising number of patients suffering from immunodeficiency disorders are fueling the blood plasma derivatives market growth.
Based on type, the blood plasma derivatives market is segmented into albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. The immunoglobulins segment held the largest market share in 2021 and is anticipated to register the highest CAGR during the forecast period. Human immunoglobulin (Ig) is used in clinical practices to treat primary immunodeficiencies. Applications of Ig increased rapidly as its anti-inflammatory and immunomodulatory functions were elucidated. Currently, Ig is the most commonly used blood product. It is obtained by processing plasma. These methods help increase the safety and quality of blood products. Ig was first used to treat primary immunodeficiencies; indications for its use have increased greatly over the last 30 years. Therefore, it has become the primary or adjuvant treatment for various autoimmune and inflammatory diseases due to its immunomodulatory and anti-inflammatory properties.
The World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), National Institute of Biologicals (NIB), and Plasma Protein Therapeutics Association (PPTA) are a few key primary and secondary sources referred to while preparing the report on the blood plasma derivatives market.
Global Blood Plasma Derivatives Market Growth Opportunity: Incorporation of Platelet-Rich Plasma in Regenerative Medicine:
Evidence has shown that micro-needling (MN) and topical application, along with PRP, improve collagen production and skin tightening for vampire facials. According to the report “Combined micro needling with topical application of platelet-rich plasma versus micro-needling alone in the treatment of stria distensae” published in 2020, MN-PRP was associated with an excellent improvement of skin lesions of Striae distensae (SD), more significant deposition of collagen and elastic fibers, increased proliferative activity in epidermis, and decreased caspase-3 protein expression values in epidermis. It has also been used to treat skin pigmentation disorders and acne scars. In hair transplants, PRP can bind to growth factors and elevates the proliferation of human derma papilla cells leading to the formation and maintenance of hair follicles.
PRP contains a platelet concentrate. A high concentration of platelets can release various growth factors after activation that can promote the proliferation and differentiation of tissue cells, accelerating tissue regeneration. PRP therapy has also been utilized for musculoskeletal regeneration to heal sports and orthopedic-associated injuries. PRP-based treatments have proved beneficial in healing acute hamstring-associated injuries, as per the National Institute of Health (NIH) report.
PRP injections are gaining popularity for treating various conditions, from sports injuries to hair loss. PRP can be widely used in regenerative medicines owing to its tissue regeneration capability, which is likely to provide lucrative opportunities for the blood plasma derivatives market in the coming years
Go through further research published by The Insight Partners: (Purchase with 10% Instant Discount):
Blood Plasma Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Blood Plasma Thawer Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Albumin Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Immunoglobulin Market Forecast to 2028 - Covid-19 Impact and Global Analysis
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/blood-plasma-derivatives-market